CertaraCERT
Market Cap: 2.53B
About: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Employees: 1,391
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
230% more call options, than puts
Call options by funds: $178K | Put options by funds: $54K
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
3% more funds holding
Funds holding: 209 [Q4 2023] → 216 (+7) [Q1 2024]
10% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 72
3% more capital invested
Capital invested by funds: $2.08B [Q4 2023] → $2.14B (+$59.6M) [Q1 2024]
0.87% more ownership
Funds ownership: 73.87% [Q4 2023] → 74.74% (+0.87%) [Q1 2024]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2023] → 2 (+0) [Q1 2024]
Research analyst outlook
6 Wall Street Analysts provided 1 year price forecasts over the past 6 months
6 analyst ratings
Keybanc Scott Schoenhaus | 27%upside $20 | Overweight Maintained | 11 Jul 2024 |
Barclays Luke Sergott | 2%upside $16 | Equal-Weight Maintained | 28 Jun 2024 |
Keybanc Scott Schoenhaus | 46%upside $23 | Overweight Upgraded | 10 Apr 2024 |
UBS Dan Leonard | 27%upside $20 | Neutral Maintained | 1 Mar 2024 |
Jefferies David Windley | 1%downside $15.5 | Hold Maintained | 1 Mar 2024 |